BR9911300A - Composto, composição farmacêutica, e, uso do composto - Google Patents

Composto, composição farmacêutica, e, uso do composto

Info

Publication number
BR9911300A
BR9911300A BR9911300-7A BR9911300A BR9911300A BR 9911300 A BR9911300 A BR 9911300A BR 9911300 A BR9911300 A BR 9911300A BR 9911300 A BR9911300 A BR 9911300A
Authority
BR
Brazil
Prior art keywords
alkyl
compound
quinolinyl
iso
compounds
Prior art date
Application number
BR9911300-7A
Other languages
English (en)
Inventor
Johannes Egbertus Maria Basten
Constant Adriaan Anton Boeckel
Rogier Christian Buijsman
Cornelia Maria Dreef-Tromp
Original Assignee
Akzo Nobel Nv
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Univ Leiden filed Critical Akzo Nobel Nv
Publication of BR9911300A publication Critical patent/BR9911300A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, USO DO COMPOSTO" A presente invenção refere-se a compostos de fórmula (I), em que R^ 1^ é fenila, naftila, 1,2,3,4-tetraidronaftila, (iso)quinolinila, tetraidro(iso)quinolinila, 3,4-diidro-1H-isoquinolinila, cromanila ou o grupo cânfora, grupos que podem ser opcionalmente substituídos por um ou mais substituintes selecionados dentre (1-8C)alquila ou (1-8C)alcóxi; R^ 2^ e R^ 3^ são, independentemente, H ou (1-8C)alquila; R^ 4^ é (1-8C)alquila ou (3-8C)cicloalquila; ou R^ 3^ e R^ 4^ juntamente com o átomo de nitrogênio ao qual estão ligados são um anel não-aromático com 4-8 membros opcionalmente contendo outro heteroátomo, sendo que o anel é opcionalmente substituído por (1-8C)alquila ou SO~ 2~-(1-8C)alquila; Q é um espaçador com um comprimento de cadeia de 10 a 70 átomos; e Z é um radical de oligossacarídeo carregado negativamente compreendendo de duas a seis unidades de monossacarídeos, sendo que a carga é compensada por contra-íons carrregados positivamente; ou um seu sal farmaceuticamente aceitável ou uma pró-droga do mesmo. Os compostos da invenção apresentam atividade antitrombótica e podem ser usados no tratamento ou na prevenção de doenças relacionadas a trombina.
BR9911300-7A 1998-06-17 1999-06-11 Composto, composição farmacêutica, e, uso do composto BR9911300A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202037 1998-06-17
PCT/EP1999/004100 WO1999065934A1 (en) 1998-06-17 1999-06-11 Antithrombotic compounds

Publications (1)

Publication Number Publication Date
BR9911300A true BR9911300A (pt) 2001-04-03

Family

ID=8233825

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911300-7A BR9911300A (pt) 1998-06-17 1999-06-11 Composto, composição farmacêutica, e, uso do composto

Country Status (31)

Country Link
US (1) US6486129B1 (pt)
EP (1) EP1087992B1 (pt)
JP (1) JP4369052B2 (pt)
KR (1) KR100790910B1 (pt)
CN (1) CN1261450C (pt)
AR (1) AR019674A1 (pt)
AT (1) ATE405580T1 (pt)
AU (1) AU756493B2 (pt)
BR (1) BR9911300A (pt)
CA (1) CA2334863C (pt)
CO (1) CO5080750A1 (pt)
CY (1) CY1108567T1 (pt)
CZ (1) CZ299382B6 (pt)
DE (1) DE69939378D1 (pt)
DK (1) DK1087992T3 (pt)
ES (1) ES2312210T3 (pt)
HK (1) HK1034266A1 (pt)
HU (1) HU229088B1 (pt)
ID (1) ID26614A (pt)
IL (2) IL139955A0 (pt)
NO (1) NO326057B1 (pt)
NZ (1) NZ508623A (pt)
PE (1) PE20000700A1 (pt)
PL (1) PL199433B1 (pt)
PT (1) PT1087992E (pt)
RU (1) RU2225869C2 (pt)
SK (1) SK286755B6 (pt)
TR (1) TR200003710T2 (pt)
TW (1) TWI221156B (pt)
WO (1) WO1999065934A1 (pt)
ZA (1) ZA200007075B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69939378D1 (de) * 1998-06-17 2008-10-02 Organon Nv Antithrombotische verbindungen
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
DE10300049A1 (de) * 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
ATE377017T1 (de) * 2002-01-31 2007-11-15 Morphochem Ag Komb Chemie Verbindungen, die faktor xa-aktiv t inhibieren
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
AU2006301240A1 (en) * 2005-10-10 2007-04-19 Msd Oss B.V. Antithrombotic compound
US8183228B2 (en) * 2005-10-10 2012-05-22 MSD OSS B.V. Netherlands Anticoagulant antithrombotic dual inhibitors comprising a biotin label
US8597632B2 (en) * 2008-10-03 2013-12-03 Glycan Biosciences Llc Anionic oligosaccharide conjugates
AU2020300002A1 (en) 2019-07-01 2022-02-24 Tonix Pharma Limited Anti-CD154 antibodies and uses thereof
US20240059781A1 (en) 2021-01-06 2024-02-22 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
DE4115468A1 (de) 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
NZ264340A (en) * 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
DE69939378D1 (de) * 1998-06-17 2008-10-02 Organon Nv Antithrombotische verbindungen

Also Published As

Publication number Publication date
WO1999065934A1 (en) 1999-12-23
DE69939378D1 (de) 2008-10-02
NZ508623A (en) 2002-11-26
RU2225869C2 (ru) 2004-03-20
NO326057B1 (no) 2008-09-08
NO20006317L (no) 2001-02-14
PL199433B1 (pl) 2008-09-30
AU756493B2 (en) 2003-01-16
ZA200007075B (en) 2002-02-28
TWI221156B (en) 2004-09-21
CO5080750A1 (es) 2001-09-25
US6486129B1 (en) 2002-11-26
AU4512999A (en) 2000-01-05
PT1087992E (pt) 2008-10-17
IL139955A0 (en) 2002-02-10
CY1108567T1 (el) 2014-04-09
HU229088B1 (en) 2013-07-29
JP4369052B2 (ja) 2009-11-18
CN1261450C (zh) 2006-06-28
CZ299382B6 (cs) 2008-07-09
JP2002518407A (ja) 2002-06-25
TR200003710T2 (tr) 2001-04-20
CA2334863C (en) 2011-02-15
ATE405580T1 (de) 2008-09-15
SK19222000A3 (sk) 2001-07-10
IL139955A (en) 2006-08-20
ID26614A (id) 2001-01-25
CZ20004735A3 (cs) 2001-08-15
EP1087992A1 (en) 2001-04-04
KR100790910B1 (ko) 2008-01-03
CN1305494A (zh) 2001-07-25
DK1087992T3 (da) 2008-11-24
PE20000700A1 (es) 2000-08-14
CA2334863A1 (en) 1999-12-23
KR20010052943A (ko) 2001-06-25
HK1034266A1 (en) 2001-10-19
NO20006317D0 (no) 2000-12-12
PL345238A1 (en) 2001-12-03
ES2312210T3 (es) 2009-02-16
SK286755B6 (sk) 2009-05-07
EP1087992B1 (en) 2008-08-20
HUP0102764A2 (hu) 2001-12-28
HUP0102764A3 (en) 2003-11-28
AR019674A1 (es) 2002-03-13

Similar Documents

Publication Publication Date Title
BR9911300A (pt) Composto, composição farmacêutica, e, uso do composto
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
DE69328192T2 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
KR940701264A (ko) 안과질환에 대한 마크로라이드 화합물의 용도
UA41865C2 (uk) Сполуки цефему, що мають антимікробну активність, та фармацевтична композиція, що їх містить
NO975901L (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
AR032607A1 (es) Composiciones farmaceuticas que contienen sales de hidroxieicosatetraenoato, y el uso de las mismas para la manufactura de un medicamento para el tratamiento de desordenes del ojo seco
IL77452A0 (en) Derivatives of arylcyclobutylalkylamines,their preparation and pharmaceutical compositions containing them
BRPI0518560A2 (pt) composto antitrombàtico, composiÇço farmacÊutica, processo para a preparaÇço do composto e uso do composto
BRPI0409088A (pt) composições farmacêuticas para administração intranasal de ácido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0]non-1(7)-en-2-il)alquil]-fosfÈnico e derivados e métodos de uso dos mesmos
GB1515241A (en) Beta-lactam antibiotics
ES2131300T3 (es) Derivados triciclicos y composiciones farmaceuticas que los contienen.
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR900014385A (ko) 제약학적 치료
HUT60275A (en) Process for producing 7-acyl-3-(substituted carbamoyloxy)-cef-3-em-4-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds
ES2172294T3 (es) Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR0112338A (pt) Composto, composição farmacêutica, e, uso de um composto
BR0013375A (pt) Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação
BR9800956A (pt) Composição farmacêutica que age por inibição das serinas proteases, e, medicamento
SE7513126L (sv) Nya kvevehaltiga, polycykliska foreningar jemte sett for deras framstellning
ATE28632T1 (de) Piperidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CO4770960A1 (es) Composiciones antagonistas receptoras de butilsulfonilamino fibrinogeno para inhibir la agregacion de plaquetas
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNIVERSITY LEIDEN (NL) , MSD OSS B.V. (NL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25A Requested transfer of rights approved

Owner name: UNIVERSITY LEIDEN (NL) , ORGANON BIOSCIENCES NEDER

B25A Requested transfer of rights approved

Owner name: UNIVERSITY LEIDEN (NL) , MERCK SHARP AND DOHME B.V

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time